OCMAX | SGGDX | OCMAX / SGGDX | |
Total Expense Ratio | 1.94 | 1.16 | 167% |
Annual Report Gross Expense Ratio | 1.94 | 1.16 | 167% |
Fund Existence | 15 years | 32 years | - |
Gain YTD | 25.953 | 21.107 | 123% |
Front Load | N/A | 5% | - |
Min. Initial Investment | 1000 | 2500 | 40% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 87.9M | 3.03B | 3% |
Annual Yield % from dividends | 1.72 | 4.00 | 43% |
Returns for 1 year | 37.00 | 23.87 | 155% |
Returns for 3 years | 16.15 | 22.30 | 72% |
Returns for 5 years | 86.95 | 58.72 | 148% |
Returns for 10 years | 77.42 | 127.73 | 61% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
FDWM | 20.80 | 1.77 | +9.28% |
Fidelity Women's Leadership ETF | |||
AVSD | 57.87 | 4.03 | +7.48% |
Avantis Responsible International Eq ETF | |||
FMED | 22.85 | 1.42 | +6.63% |
Fidelity Disruptive Medicine ETF | |||
ACIO | 37.97 | 1.61 | +4.44% |
Aptus Collared Investment Opp ETF | |||
TBUX | 49.58 | -0.01 | -0.02% |
T. Rowe Price Ultra Short-Term Bond ETF |